- Home
- OGS vs ACLX Comparison
OGS vs ACLX Comparison
Compare OGS & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OGS
- ACLX
- Stock Information
- Founded
- OGS 1906
- ACLX 2015
- Country
- OGS United States
- ACLX United States
- Employees
- OGS N/A
- ACLX N/A
- Industry
- OGS Oil/Gas Transmission
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- OGS Utilities
- ACLX Health Care
- Exchange
- OGS Nasdaq
- ACLX Nasdaq
- Market Cap
- OGS 4.9B
- ACLX 4.4B
- IPO Year
- OGS N/A
- ACLX 2022
- Fundamental
- Price
- OGS $83.62
- ACLX $73.40
- Analyst Decision
- OGS Buy
- ACLX Strong Buy
- Analyst Count
- OGS 8
- ACLX 9
- Target Price
- OGS $81.19
- ACLX $115.50
- AVG Volume (30 Days)
- OGS 488.4K
- ACLX 909.3K
- Earning Date
- OGS 11-03-2025
- ACLX 11-05-2025
- Dividend Yield
- OGS 3.23%
- ACLX N/A
- EPS Growth
- OGS 11.73
- ACLX N/A
- EPS
- OGS 4.27
- ACLX N/A
- Revenue
- OGS $2,368,759,000.00
- ACLX $35,898,000.00
- Revenue This Year
- OGS $23.78
- ACLX N/A
- Revenue Next Year
- OGS $4.30
- ACLX $220.95
- P/E Ratio
- OGS $19.42
- ACLX N/A
- Revenue Growth
- OGS 15.06
- ACLX N/A
- 52 Week Low
- OGS $66.38
- ACLX $47.86
- 52 Week High
- OGS $83.66
- ACLX $96.39
- Technical
- Relative Strength Index (RSI)
- OGS 62.06
- ACLX 29.61
- Support Level
- OGS $82.09
- ACLX $71.05
- Resistance Level
- OGS $83.62
- ACLX $92.70
- Average True Range (ATR)
- OGS 1.19
- ACLX 5.19
- MACD
- OGS 0.13
- ACLX -2.07
- Stochastic Oscillator
- OGS 98.54
- ACLX 9.49
About OGS ONE Gas Inc.
ONE Gas Inc is a regulated natural gas utility company. It is involved in the distribution and sale of natural gas to residential, commercial, industrial, and transportation consumers through its network of pipelines and service lines. Almost all of the company's revenue is derived from natural gas sales in the states of Oklahoma, Kansas, and Texas. The company controls considerable market shares in Oklahoma and Kansas.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.